🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Synflorix™

Found 35 matching trials

Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines

PHASE3

The purpose of this observer blind study is to assess the safety in terms o...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-10-22

Trial ID

NCT00547248

Treatments Being Tested

Synflorix Tritanrix-HepB Hiberix Polio Sabin Poliorix Prevenar (Wyeth)

Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants

PHASE2

This study will assess the impact on nasopharyngeal carriage, safety and im...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-02-09

Trial ID

NCT01262872

Treatments Being Tested

Pneumococcal vaccine GSK 2189242A (LD formulation 1)Pneumococcal vaccine GSK 2189242A (HD formulation 2)Synflorix™Prevnar13™Tritanrix™-HepB/Hib Polio Sabin™M-Vac™Stamaril™

Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka

N/A

This PMS study aims to collect safety and reactogenicity data of Synflorix™...

Status

Withdrawn

Location

Multiple Locations

Start Date

2013-04

Trial ID

NCT01803425

Treatments Being Tested

Synflorix™ data collection

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine

PHASE3

This study will evaluate safety, reactogenicity and immunogenicity of GSK B...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-08-07

Trial ID

NCT00344318

Treatments Being Tested

Pneumococcal conjugate vaccine GSK1024850A Prevenar Tritanrix-HepB Hiberix Polio Sabin.Poliorix.

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

PHASE2

This study will evaluate the safety and immunogenicity of GSK Biologicals' ...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-08-13

Trial ID

NCT00970307

Treatments Being Tested

GSK2202083A vaccine 10-valent pneumococcal vaccine (GSK 1024850A)Infanrix hexa™Menjugate®

Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

PHASE3

This study will evaluate the safety, reactogenicity and immunogenicity of a...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-09-25

Trial ID

NCT00370396

Treatments Being Tested

Synflorix Prevenar Infanrix hexa

Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™

PHASE3

The purposes of this study are: To demonstrate the immunogenicity in terms...

Status

Completed

Location

GSK Investigational Site

Start Date

2008-06-10

Trial ID

NCT00680914

Treatments Being Tested

Pneumococcal vaccine GSK1024850A (Synflorix)Prevenar GSK Biologicals' Hiberix™

Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines

PHASE3

The purpose of this study is to evaluate immunogenicity and safety of menin...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-07-01

Trial ID

NCT01144663

Treatments Being Tested

Nimenrix™Menjugate®NeisVac-CTM Infanrix™ hexa Synflorix™

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants

PHASE2

This study will assess the safety, reactogenicity and immunogenicity of two...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-09-27

Trial ID

NCT01204658

Treatments Being Tested

Pneumococcal vaccine GSK 2189242A (LD formulation 1)Pneumococcal vaccine GSK 2189242A (HD formulation 2)Synflorix Prevenar 13 Infanrix Hexa (DTPa-HBV-IPV/Hib)

Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™

PHASE3

The purpose of this study is to assess the immunogenicity in terms of antib...

Status

Completed

Location

GSK Investigational Site

Start Date

2008-06-18

Trial ID

NCT00678301

Treatments Being Tested

GSK Biologicals' Synflorix™GSK Biologicals' Polio Sabin™GSK Biologicals' Zilbrix™ Hib

Previous Next